Approval · Notice of Compliance 30717 · 2023
ONAKTA: Notice of Compliance 30717
Issued May 12, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30717
- Date
- May 12, 2023
- Company
- Avir Pharma IncBlainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONAKTA | 02537818 | Approved |
Medicinal ingredients
- TIRBANIBULIN 1 PER